Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

31/01/2024 07:00

Jan 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              389.90              339.02           500.00    
                   (+15.0 pct)         (+24.9 pct)      (+11.8 pct) 
  Operating          144.63              122.59           167.00    
                   (+18.0 pct)         (+49.2 pct)      (+17.6 pct) 
  Pretax             147.29              124.38           169.00    
                   (+18.4 pct)         (+47.5 pct)      (+17.7 pct) 
  Net                110.54               95.66           126.00    
                   (+15.6 pct)         (+48.0 pct)      (+11.8 pct) 
  EPS Basic        229.08 yen          195.90 yen       259.36 yen  
  EPS Diluted      229.06 yen          195.88 yen                   
  Ann Div                               70.00 yen        80.00 yen  
  -Q2 Div           40.00 yen           33.00 yen                   
  -Q4 Div                               37.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T